News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

ANN MARIE PORRECA, PHARMD, BCPS

Advertisement

Articles by ANN MARIE PORRECA, PHARMD, BCPS

Treatment Options to Address the Threat of Carbapenem-Resistant Enterobacteriaceae

ByANN MARIE PORRECA, PHARMD, BCPS,Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
April 17th 2018

New agents are in development, but none represent a magic bullet for the problems that CRE infections present.

Advertisement

Latest Updated Articles

  • Treatment Options to Address the Threat of Carbapenem-Resistant Enterobacteriaceae
    Treatment Options to Address the Threat of Carbapenem-Resistant Enterobacteriaceae

    Published: April 17th 2018 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance

2

Misdiagnosis Common in Skin Infections Due to Overlapping Noninfectious Conditions

3

As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link

4

Cefiderocol is Noninferior, But not "Game-Changer," for Gram-negative Bloodstream Infections

5

Emerging Diagnostic Tools and Mycobacterial Challenges in Skin and Soft Tissue Infections

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us